Balyasny Asset Management »

Taysha Gene Therapies shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $371k 83k 4.47
2025-12-31 $231k 42k 5.50
2024-03-31 $542k 189k 2.87

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Group
State Street Corporation
Vanguard Capital Management
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays

View all funds holding Taysha Gene Therapies